ng-nitroarginine methyl ester has been researched along with Parkinson Disease in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Fazli-Tabaei, S; Khakpai, F; Zarrindast, MR | 1 |
Cadet, P; Neuwirth, LS; Zhu, W | 1 |
Ansah, T; Channon, KM; Charlton, C; Gangula, PR; Hale, A; Kalpana, R; Sampath, C; Srinivasan, S | 1 |
Agarwal, AK; Chaturvedi, RK; Das, T; Dikshit, M; Ravindran, A; Shukla, Y; Singh, S | 1 |
Obata, T; Yamanaka, Y | 1 |
Barthwal, MK; Dikshit, M; Srivastava, N | 1 |
Cho, KG; Jin, BK; Joe, EH; Kim, J; Kim, SU; Lee, YB; Oh, YJ; Ryu, JK; Shin, WH | 1 |
7 other study(ies) available for ng-nitroarginine methyl ester and Parkinson Disease
Article | Year |
---|---|
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis.
Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Male; Memory; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Parkinson Disease; Quinpirole; Receptors, Dopamine D2; Sulpiride | 2021 |
Regulation of the Endogenous Opiate Signaling Pathway against Oxidative Stress and Inflammation: A Considerable Approach for Exploring Preclinical Treatment of Parkinson's Disease.
Topics: Animals; Dopaminergic Neurons; Humans; Inflammation; Morphine; Naloxone; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Oxidative Stress; Oxidopamine; Parkinson Disease; Rotenone; Signal Transduction | 2023 |
Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Animals; Biopterins; Blotting, Western; Colon; Constipation; Disease Models, Animal; Enzyme Inhibitors; Gastric Emptying; Gastrointestinal Motility; Gene Expression Regulation; Heme Oxygenase-1; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; MPTP Poisoning; NF-E2-Related Factor 2; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Parkinson Disease; Parkinsonian Disorders; Tyrosine 3-Monooxygenase | 2019 |
Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease.
Topics: Animals; Brain; Female; Lipopolysaccharides; Male; Neurodegenerative Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2005 |
Nitric oxide enhances MPP(+)-induced hydroxyl radical generation via depolarization activated nitric oxide synthase in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Allopurinol; Animals; Dopamine; Enzyme Inhibitors; Extracellular Space; Herbicides; Hydroxybenzoates; Hydroxyl Radical; Iron; Iron Chelating Agents; Male; Membrane Potentials; Microdialysis; Neostriatum; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Parkinson Disease; Potassium; Rats; Rats, Wistar | 2001 |
Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Enzyme Inhibitors; Homovanillic Acid; Male; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2001 |
Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia.
Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Avian Proteins; Basigin; Blood Proteins; Cell Death; Dopamine; Enzyme Inhibitors; Female; Gangliosides; Gliosis; Immunohistochemistry; Membrane Glycoproteins; Microglia; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2002 |